The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

BACKGROUND: The outcome of patients who progress on front-line immune-based combination regimens (IC) including immune checkpoint inhibitors (CPI) and receive subsequent systemic therapy is unknown. METHODS: Retrospective analysis of consecutive patients with clear-cell mRCC who progressed on one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Barata, Pedro Coelho, De Liano, Alfonso Gomez, Mendiratta, Prateek, Crolley, Valerie, Szabados, Bernadett, Morrison, Laura, Wood, Laura, Allman, Kimberly, Tyler, Allison, Martin, Allison, Gilligan, Timothy, Grivas, Petros, Ornstein, Moshe, Garcia, Jorge A., Powles, Thomas, Rini, Brian I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048048/
https://www.ncbi.nlm.nih.gov/pubmed/29795307
http://dx.doi.org/10.1038/s41416-018-0104-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048048/
https://www.ncbi.nlm.nih.gov/pubmed/29795307
http://dx.doi.org/10.1038/s41416-018-0104-z

Ejemplares similares